Patients receiving androgen deprivation therapy for prostate cancer have an increased risk of depressive disorder

about

Effects of Androgen Deprivation Therapy on Pain Perception, Quality of Life, and Depression in Men With Prostate Cancer.No increased risk of psoriasis in patients receiving androgen deprivation therapy for prostate cancer: a 17-year population-based study

P2860

Q47760342-7D8B7BCB-CC9E-43AD-81E8-6489B792810D Q57490622-8312BAB4-CE7E-4084-98C3-86D9FE0FEC76

P2860

Patients receiving androgen deprivation therapy for prostate cancer have an increased risk of depressive disorder

Item

http://www.wikidata.org/entity/Q36295478

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Patients receiving androgen de ...... ed risk of depressive disorder

@ast

Patients receiving androgen de ...... ed risk of depressive disorder

@en

type

Item

label

Patients receiving androgen de ...... ed risk of depressive disorder

@ast

Patients receiving androgen de ...... ed risk of depressive disorder

@en

prefLabel

Patients receiving androgen de ...... ed risk of depressive disorder

@ast

Patients receiving androgen de ...... ed risk of depressive disorder

@en

P1476

Patients receiving androgen de ...... ed risk of depressive disorder

@en

P2093

Chung-Chien Huang

http://www.w3.org/2001/XMLSchema#string

Herng-Ching Lin

http://www.w3.org/2001/XMLSchema#string

Shiu-Dong Chung

http://www.w3.org/2001/XMLSchema#string

Sudha Xirasagar

http://www.w3.org/2001/XMLSchema#string

P2860

Quality of life issues in men undergoing androgen deprivation therapy: a review

Adverse effects of androgen deprivation therapy and strategies to mitigate them.

Increased incidence of diagnosed depressive illness in hypogonadal older men.

Increased Risk of Depressive Disorder following Cholecystectomy for Gallstones

The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.

Medical castration with LHRH agonists: 25 years later with major benefits achieved on survival in prostate cancer.

Complications of androgen deprivation therapy in men with prostate cancer.

Risk of the "androgen deprivation syndrome" in men receiving androgen deprivation for prostate cancer.

Impact of androgen-deprivation therapy on the immune system: implications for combination therapy of prostate cancer.

Association of Androgen Deprivation Therapy With Depression in Localized Prostate Cancer

P304

e0173266

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0173266

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hsin-Chien Lee

Li-Ting Kao

P577

2017-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28253340

http://www.w3.org/2001/XMLSchema#string

P932

5333913

http://www.w3.org/2001/XMLSchema#string

Patients receiving androgen deprivation therapy for prostate cancer have an increased risk of depressive disorder

about

P2860

P2860

Patients receiving androgen deprivation therapy for prostate cancer have an increased risk of depressive disorder

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932